CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
USD |
NASDAQ |
Mar 21, 16:00
CymaBay Therapeutics Profit Margin (Quarterly): -73.51K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 39.21% |
| Assure Holdings Corp. | -- |
| Societal CDMO Inc (DELISTED) | -2.84% |
| AN2 Therapeutics, Inc. | -- |
| Madrigal Pharmaceuticals, Inc. | -39.75% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -60.75% |
| Return on Assets | -35.13% |
| Return on Invested Capital | -38.61% |
| Operating Margin (Quarterly) | -74.56K% |
| Return on Net Operating Assets | -5.27K% |